We herein demonstrate the significant impact of the bone and soft tissue microenvironments on prostate cancer growth and tumor microvascular properties in vivo during a period of 21 days by intravital microscopy of the FW and DSC.
Advantages and limitations of the tumor model
In recent years, many indirect observation methods were developed to analyze tumor growth in bone and the morphological and functional aspects of angiogenesis. Because rodents do not commonly form spontaneous bone metastases, designing a research model is difficult [
22]. Xenograft models generated by implantation of human tumor cells into immunodeficient mice considerably improved our understanding of the tumor microenvironment [
23‐
25]. But the results obtained on immunodeficient mice cannot be directly translated onto the human biology. Experimental metastases are commonly generated by intracardial or intratibial injection of cancer cells to induce bone metastasis [
26,
27]. Although intracardial injection mimics the process of metastasis, the site of bone metastases and the time of development cannot be controlled in the study design. Another frequently used procedure is the subcutaneous application of tumor cells and subsequent postmortem evaluation, which is useful for histological examination; however, similar to the previous model, this design does not permit continuous in vivo imaging of functional microvascular alterations during tumor growth [
28]. Models that use direct inoculation of tumor cells into bone, as described in this study, mimic the final stages of bone colonization, whereas they do not address the proliferation of primary neoplasm, intravasation into blood vessels, extravasation into bone marrow, tumor cell dormancy, paracrine local tissue and activation of the tumor cells. In addition, the role of intact immune system as controlling the tumor growth can not be analyzed with the presented model [
29]. Furthermore, the direct inoculation of a large number of tumor cells may generate a different initial tumor size. The difference in tumor size is a weakness in this study since tumor microcirculation may vary with size of the tumor.
In addition to the difficulties associated with generating bone metastases in rodents within a defined time frame and at a specific growth site, monitoring tumor growth and angiogenesis in bone is difficult. Bauerle et al. investigated bone metastasis in nude rats using magnetic resonance imaging, volumetric computed tomography, and ultrasonography [
30]. These technologies can be used to assess tumor growth and detect solid metastases; however, these methods are limited regarding the detection of tumors at the early stages of formation or the visualization of functional microvascular changes associated with tumor growth in vivo in real time [
31]. Imaging technologies lack spatial resolution or the ability to monitor morphological and functional aspects of microcirculation during tumor growth. In this context, intravital microscopy using transparent chamber techniques is a successful approach to investigate the microcirculatory properties of various tissues at a high spatial resolution [
7,
12,
13,
32‐
34].
Each model offers advantages and disadvantages, and no single ideal model exists. Intravital fluorescence microscopy provides anatomical and functional insight into tumor pathophysiology, including angiogenesis and the microenvironment in vivo, in a non-invasive and non-destructive manner [
4].
Bone tissue increases the take rate in the prostate cancer cell lines LnCap and Pc3 and is associated with reduced early tumor growth
A large body of literature indicates that the tumor microenvironment is crucial for tumor progression and the response to treatment [
9]. The host tissue determines tumor cell survival and growth via molecular interactions [
35]. Consistent with previous studies, we showed that the microenvironment affected the tumor take rate [
36,
37]. The tumor take rate was approximately one third higher in bone tissue than in muscle for all three cell lines despite equal amounts of inoculated tumor cells. The cell lines used were suitable for experimental studies of bone metastasis with engraftment rates of over 66%. However, the use of Pc3 cells in xenograft DSC models in NSG mice is limited because of the low engraftment rates in striated muscle.
Despite the higher engraftment rates, the initial tumor size for the three cell lines was nearly 50% smaller in bone than in muscle on day 7 (Fig.
2a and Additional file
3: Table S1). In addition to paracrine survival factors, which influence take rate, the microcirculation of the host tissue has a major impact on tumor growth because the survival and growth of cells depends on an adequate supply of oxygen and nutrients [
38]. Pre-existing host vessels support or limit early tumor growth before angiogenesis [
39]. Since the diffusion of oxygen is limited to 150–200 μm [
40], the higher functional vascular density and consequent decrease in intervascular distance in striated muscle may promote early tumor growth compared with that in bone tissue. These observations are in line with the microvascular architecture in the dorsal skinfold chamber that presents the usual striated muscle with regular microvessel anatomy [
41]. In contrast, the blood supply in bone is guaranteed by fenestrated capillaries (longitudinal and transverse canals) [
42,
43]. This system, normally allows the intravasation of developing myeloid cells into the blood due to the large pores present [
44]. These pores (30–40 μm) may facilitate extravasation for tumor cells and therefore support tumor growth in bone.
The microvascular properties of bone substantially promote tumor growth in LnCap and Pc3 tumors
Analysis of tumor size according to initial tumor area on day 7 demonstrated a pronounced growth rate in LnCap and Pc3 tumors in the bone microenvironment (Fig.
2b). The rapid tumor growth led to femur fractures after 14 days in LnCap and after 21 days in Pc3 mice. Despite the mixed osteolytic/osteoblastic pattern of LnCap tumors compared with the osteolytic growth of Pc3 cells, pathologic fractures were delayed in Pc3 tumors compared with those of LnCap cells [
45]. This can be attributed to the difference in absolute tumor size, as the initial tumor burden was 50% lower in Pc3 tumors on day 7. Tumor growth was markedly lower in Du145 tumors than in those derived from other cell lines and corresponded to their counterparts grown in striated muscle tissue. The slow tumor growth in bone was consistent with previous observations [
45].
Tumor growth beyond a few cubic millimeters is angiogenesis-dependent [
46]. Angiogenesis is a prerequisite for tumor growth, whereas vessel density is not necessarily accompanied by tissue perfusion, and temporal variation during tumor growth needs to be assessed; therefore, intravital microscopy provides a detailed insight into tumor biology [
34,
47,
48]. To determine whether the microvascular properties accounted for the differences in tumor growth between secondary bone and soft tissue tumors, we analyzed the functional and morphological aspects of tumor vessels.
Angiogenesis involves multiple interdependent steps, as described in previous studies [
49]. One of the first steps is the degradation of the basement membrane, as indicated by increased PERM [
50,
51]. Due to the vascular architecture in bone the effective vascular permeability was higher in the femur window than in the dorsal skinfold chamber. This may facilitate the first step in angiogenesis. Secondary bone tumors were associated with increased permeability compared with that in striated muscle tissue. This may promote prostate cancer growth in bone and contribute to impaired drug delivery via increased interstitial pressure [
52,
53]. Knowledge of local bone vascularization, including PERM, could be essential for preventing the formation of secondary bone tumors in prostate cancer patients [
54].
The lower vascular density of bone tumors, in particular LnCap and Du145 tumors, indicated that high vascularity is not necessarily associated with accelerated tumor growth, as microvessel density does not reflect the metabolic demand of a tumor [
55]. Furthermore, we showed that, despite the lower vascular density, increased blood flow and vascular diameter resulted in increased tissue perfusion rates in bone tumors. Under physiological conditions, the tissue perfusion rate was similar between bone and striated muscle tissue in NSG mice, as previously demonstrated [
56]. The different organ environments differentially affected tumor growth. The higher perfusion rate may have contributed to the accelerated tumor growth of Pc3 and LnCap tumors. The tumor size of Du145 was decreased. This could be associated with paracrine/autocrine mechanisms, which greatly contribute to tumor progression [
57]. These paracrine factors may be crucial for the growth characteristics in both tissues. In bone, the osteocytes support cancer progression by cytokines production [
58]. Furthermore, the osteoclasts are stimulated by tumor induced osteolytic factors (RANKL expression, Parathyroid hormone-related protein, Interleukin-6, matrix metalloproteinases and cathepsins). These factors induce (amongst others) the degradation of extracellular matrix and mineralized bone and increased invasion and migration of tumor cells [
59].
The increased blood flow velocity of Du145 tumors, which was considerably greater than that of other cell lines and tissues, may have further contributed to this phenomenon because of impaired substrate exchange. The steady growth of Du145 tumors with high engraftment rates in bone and striated muscle could be used in subsequent studies to compare the effects of treatments for prostate cancer metastasis in both tissues.